Omega Healthcare Investors (NYSE:OHI) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $3.00-3.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.06.
Several research firms have commented on OHI. Zacks Investment Research cut Omega Healthcare Investors from a buy rating to a hold rating in a report on Tuesday, February 12th. Stifel Nicolaus cut Omega Healthcare Investors from a buy rating to a hold rating and set a $39.00 target price for the company. in a report on Thursday, February 7th. ValuEngine cut Omega Healthcare Investors from a buy rating to a hold rating in a report on Wednesday, April 3rd. Finally, Scotiabank assumed coverage on Omega Healthcare Investors in a report on Thursday, February 7th. They issued a sector perform rating and a $39.37 target price for the company. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Omega Healthcare Investors presently has a consensus rating of Hold and an average price target of $35.80.
Shares of OHI traded up $0.52 during mid-day trading on Thursday, reaching $36.50. The company had a trading volume of 1,010,872 shares, compared to its average volume of 1,755,074. Omega Healthcare Investors has a twelve month low of $27.71 and a twelve month high of $40.30. The company has a current ratio of 3.93, a quick ratio of 3.93 and a debt-to-equity ratio of 1.21. The stock has a market cap of $7.39 billion, a PE ratio of 12.00, a PEG ratio of 4.70 and a beta of 0.46.
Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Tuesday, May 7th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.71 by ($0.37). Omega Healthcare Investors had a return on equity of 7.37% and a net margin of 31.94%. The company had revenue of $188.20 million during the quarter, compared to analyst estimates of $190.54 million. During the same period in the previous year, the company posted $0.78 earnings per share. The company’s quarterly revenue was down 2.9% on a year-over-year basis. On average, sell-side analysts forecast that Omega Healthcare Investors will post 2.98 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Tuesday, April 30th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, April 29th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 7.23%. Omega Healthcare Investors’s payout ratio is presently 86.84%.
In related news, COO Daniel J. Booth sold 40,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $36.51, for a total transaction of $1,460,400.00. Following the sale, the chief operating officer now directly owns 187,206 shares in the company, valued at approximately $6,834,891.06. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO C Taylor Pickett sold 22,788 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $38.04, for a total value of $866,855.52. Following the sale, the chief executive officer now owns 329,133 shares in the company, valued at $12,520,219.32. The disclosure for this sale can be found here. Over the last three months, insiders sold 65,788 shares of company stock valued at $2,440,176. 1.65% of the stock is currently owned by insiders.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
See Also: Why is total return important?